Stifel Nicolaus analyst Mark Astrachan maintained a Hold rating on Procter & Gamble (PG – Research Report) today and set a price target of ...
Barclays analyst Lauren Lieberman maintained a Hold rating on Procter & Gamble (PG – Research Report) today and set a price target of ...
HNSCC, whereas the combination of durvalumab and cetuximab showed limited success. Abenacianine received fast track designation for lung cancer surgery, the combination of amivantamab and Lazertinib ...
Shares of Perrigo Company plc (NYSE:PRGO – Get Free Report) have earned a consensus recommendation of “Hold” from the five analysts that are covering the firm, Marketbeat.com reports. Three analysts ...
Analysts at Cantor Fitzgerald upped their FY2024 earnings per share (EPS) estimates for shares of Rigel Pharmaceuticals in a ...
Across 5 research centers, investigators evaluated the impact of eculizumab on thymoma-associated myasthenia gravis, a severe ...
Reported reserves are 1.003Bt @ 0.33% Cu & 0.13 g/t Au. EL24001: 261 m of mineralization grading 0.64% copper-equivalent ...
The Department of Justice filed a lawsuit Friday against a Davenport landlord alleging he had sexually harassed female ...
During a Case-Based Roundtable® event, Rahul Banerjee, MD, discussed approaches to dosing and tolerability when using ...
VANCOUVER, BC / ACCESSWIRE / January 15, 2025 / Arras Minerals Corp. (TSXV:ARK)(OTCQB:ARRKF) ("Arras" or "Arras Minerals" or "the Company") is pleased to provide initial results for the first 3 drillh ...
Linsitinib, an oral small molecule under development for the treatment of thyroid eye disease, demonstrated proptosis reduction and safety in the phase 2b/3 LIDS trial, according to a press release ...
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...